Monoclonal antibody therapies for COVID-19: lessons learned and implications for the development of future products
Brian D. Kelley, Pam De Moor, Kristen Douglas, Todd Renshaw, Stacey Traviglia
Topics & Concepts
Coronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakMonoclonal antibodyVirologyComputational biologyAntibodyMedicineBiologyImmunologyOutbreakInternal medicineInfectious disease (medical specialty)DiseaseSARS-CoV-2 and COVID-19 ResearchCAR-T cell therapy researchMonoclonal and Polyclonal Antibodies Research